Member Info for researcher1

another useful extension - though it would be good to see some top line exponential growth sometime soon....

agreed - and I think we will in April...

the labs are independent of FDA approval (they were always designed as a parallel) and though clearly the approval will generate a stack more contracts, there are sufficient research teams/agendas/papers out there to fill the labs immediately...

that's good, keep pushing it back down please...

I wonder whether we'll see a surge once the US digests the figures? - all point to an SP between £1.50 and £2 BEFORE any new pipeline conversions

come on guys, get excited please!
hold on though - ISA time next week - suppress the price guys!

well done all - confidence restored - future is bright....so why isn't this £2????

Great work Angle - we never doubted you - and looking forward to the pharma deals (plural) before FDA approval

yes, I was wondering whether they might do that Tom, though previously AN has always stated they would likely open separately. What they may wish to do is announce the pharma deal at the same time, so there is a 'ducks-in-a-row' consideration....

announcement feels due this week, given recruitment drive and dates etc.... though I hope it comes after Easter, specifically, after April 5.... I have 3 friends recruited to the idea of Angle ISAs!

let us all remember Darren's "55-65p before the summer" and judge him accordingly?

Nasdaq is excellent once there is good news - huge potential investor base in the US - so be patient....

yes I get that Sang, and am even hopeful of sub-110 shares (as I posted on Placement day) - we'll see...

it's a fairly common occurrence for an SP to drift down to a placing price, reestablish a base and move back up from there. I wish I'd sold more than 50% of my holding at 147 but after today's re-purchase have an average of 119 (and 10% more shares) so happy with that. Sit back for a year now....

shares at close to placing price - excellent!

cheap shares ahoy! although the spread is unkind for large amounts...

thordon, calm yourself. They are working on answering FDA questions at the moment, and recruiting to the clinics - all in good time, and certainly before the summer!

can't imagine they will want to include anything racy. There might just be a 'roadmap' (cringe) which will spur the yanks to get in sooner rather than later....

doubled down (or up, actually) at 115 - great to have an extra bunch of shares close to the price management subscribed at....(thankfully I managed to sell a decent percentage in the high 140s on Monday)

yes I can see plus points too Ian - I was half-expecting we'd just get the same figures regurgitated (as we did anyway) and that the SP would drop lower than it has, on sheer boredom and frustration. To hear today that we will get forward guidance is a big plus IMO.